Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3343431 | Best Practice & Research Clinical Rheumatology | 2007 | 12 Pages |
Abstract
Excess fibrosis of the skin is a clinical hallmark of both localized scleroderma and systemic sclerosis. Localized scleroderma is generally thought to be a skin-limited disease whereas systemic sclerosis can have a wide range of internal organ involvement. Recent data suggest that a subset of patients with juvenile localized scleroderma can go on to develop systemic involvement of their disease. This raises the question of what the connection is, if any, between localized scleroderma and systemic sclerosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Rajnish A. Gupta, David Fiorentino,